Haleon Plc (HLN)
11.20
+0.04
(+0.36%)
USD |
NYSE |
Feb 13, 16:00
11.18
-0.02
(-0.18%)
Pre-Market: 20:00
Haleon Market Cap : 49.87B for Feb. 13, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Silence Therapeutics Plc | 226.72M |
| Adaptimmune Therapeutics Plc | 7.952M |
| Biodexa Pharmaceuticals Plc | 0.9059M |
| Oxford Biomedica Plc | 1.363B |
| NuCana Plc | 8.823M |
Market Cap Related Metrics
| PS Ratio | 3.577 |
| PEG Ratio | 0.7438 |
| Price to Free Cash Flow | 20.66 |
| Price | 11.20 |
| Earnings Yield | 3.86% |
| PEGY Ratio | 0.7102 |
| Operating PE Ratio | 16.23 |
| Normalized PE Ratio | 23.00 |